These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 28377550

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Triple inhalers for obstructive airways disease: will they be useful?
    Barnes PJ.
    Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649
    [No Abstract] [Full Text] [Related]

  • 23. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
    Yamauchi Y, Yasunaga H, Hasegawa W, Sakamoto Y, Takeshima H, Jo T, Matsui H, Fushimi K, Nagase T.
    Int J Chron Obstruct Pulmon Dis; 2016 Jun; 11():1403-11. PubMed ID: 27382276
    [Abstract] [Full Text] [Related]

  • 24. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL, Lin CH.
    Int J Chron Obstruct Pulmon Dis; 2016 Jun; 11():2341-2348. PubMed ID: 27703344
    [Abstract] [Full Text] [Related]

  • 25. Determinants for changing the treatment of COPD: a regression analysis from a clinical audit.
    López-Campos JL, Abad Arranz M, Calero Acuña C, Romero Valero F, Ayerbe García R, Hidalgo Molina A, Aguilar Perez-Grovas RI, García Gil F, Casas Maldonado F, Caballero Ballesteros L, Sánchez Palop M, Pérez-Tejero D, Segado A, Calvo Bonachera J, Hernández Sierra B, Doménech A, Arroyo Varela M, González Vargas F, Cruz Rueda JJ.
    Int J Chron Obstruct Pulmon Dis; 2016 Jun; 11():1171-8. PubMed ID: 27330285
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI, Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Siddiqui S, Anzueto A, Zhu H.
    Int J Chron Obstruct Pulmon Dis; 2016 Jun; 11():1921-8. PubMed ID: 27574416
    [Abstract] [Full Text] [Related]

  • 28. Inhaled treatment of COPD: a Delphi consensus statement.
    Ninane V, Corhay JL, Germonpré P, Janssens W, Joos GF, Liistro G, Vincken W, Gurdain S, Vanvlasselaer E, Lehouck A.
    Int J Chron Obstruct Pulmon Dis; 2017 Jun; 12():793-801. PubMed ID: 28293106
    [Abstract] [Full Text] [Related]

  • 29. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N.
    Int J Chron Obstruct Pulmon Dis; 2015 Jun; 10():1093-102. PubMed ID: 26089659
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC, Fairbrother SE, Scowcroft A, Chiu G, Ternouth A, Lipworth BJ.
    Int J Chron Obstruct Pulmon Dis; 2016 Jun; 11():2851-2858. PubMed ID: 27920512
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan.
    Horita N, Kaneko T.
    Int J Chron Obstruct Pulmon Dis; 2015 Jun; 10():813-22. PubMed ID: 25960646
    [Abstract] [Full Text] [Related]

  • 36. Inappropriate inhaled corticosteroid prescribing in chronic obstructive pulmonary disease patients.
    Harrison A, Borg B, Thompson B, Hew M, Dabscheck E.
    Intern Med J; 2017 Nov; 47(11):1310-1313. PubMed ID: 29105270
    [Abstract] [Full Text] [Related]

  • 37. Glycopyrrolate/formoterol (Bevespi Aerosphere) for COPD.
    Med Lett Drugs Ther; 2016 Oct 10; 58(1505):130-132. PubMed ID: 27701364
    [No Abstract] [Full Text] [Related]

  • 38. Drugs for chronic obstructive pulmonary disease.
    Treat Guidel Med Lett; 2010 Nov 10; 8(99):83-8; quiz 89-90. PubMed ID: 21045755
    [No Abstract] [Full Text] [Related]

  • 39. Patterns and characterization of COPD exacerbations using real-time data collection.
    Ejiofor SI, Stolk J, Fernandez P, Stockley RA.
    Int J Chron Obstruct Pulmon Dis; 2017 Nov 10; 12():427-434. PubMed ID: 28182151
    [Abstract] [Full Text] [Related]

  • 40. Switching treatments in COPD: implications for costs and treatment adherence.
    Braido F, Lavorini F, Blasi F, Baiardini I, Canonica GW.
    Int J Chron Obstruct Pulmon Dis; 2015 Nov 10; 10():2601-8. PubMed ID: 26664108
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.